DK2131841T3 - Fremgangsmåder til behandling af akut smerte - Google Patents
Fremgangsmåder til behandling af akut smerteInfo
- Publication number
- DK2131841T3 DK2131841T3 DK08724934.8T DK08724934T DK2131841T3 DK 2131841 T3 DK2131841 T3 DK 2131841T3 DK 08724934 T DK08724934 T DK 08724934T DK 2131841 T3 DK2131841 T3 DK 2131841T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- acute pain
- treating acute
- treating
- pain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89836207P | 2007-01-30 | 2007-01-30 | |
PCT/US2008/001187 WO2008094571A1 (en) | 2007-01-30 | 2008-01-29 | Methods for treating acute and subchronic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2131841T3 true DK2131841T3 (da) | 2012-10-15 |
Family
ID=39345258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08724934.8T DK2131841T3 (da) | 2007-01-30 | 2008-01-29 | Fremgangsmåder til behandling af akut smerte |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080181876A1 (da) |
EP (1) | EP2131841B1 (da) |
DK (1) | DK2131841T3 (da) |
ES (1) | ES2392116T3 (da) |
HK (1) | HK1139856A1 (da) |
PL (1) | PL2131841T3 (da) |
PT (1) | PT2131841E (da) |
WO (1) | WO2008094571A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2623072A1 (en) * | 2005-09-26 | 2007-04-05 | Avigen, Inc. | Use of ibudilast for treating drug and behavioral addictions |
EP2026804A1 (en) | 2006-05-31 | 2009-02-25 | Avigen, Inc. | Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
CA2669463A1 (en) * | 2006-11-09 | 2008-05-15 | Avigen, Inc. | Method for treating delirium |
WO2008137012A1 (en) * | 2007-05-03 | 2008-11-13 | Avigen, Inc. | Use of a glial attenuator to prevent amplified pain responses caused by glial priming |
CA2785056A1 (en) | 2009-12-22 | 2011-07-21 | Pondera Biotechnologies, LLC | Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications |
US9980900B2 (en) | 2015-12-22 | 2018-05-29 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
US9693949B1 (en) | 2015-12-22 | 2017-07-04 | Revogenex Ireland Ltd | Intravenous administration of tramadol |
WO2019148047A1 (en) * | 2018-01-25 | 2019-08-01 | Cognifisense, Inc. | Combinatorial therapeutic systems and methods |
US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5229318B2 (da) | 1972-03-30 | 1977-08-01 | ||
US4097483A (en) | 1974-11-01 | 1978-06-27 | Kyorin Pharmaceutical Co., Ltd. | Pyrazolo 1,5-a!pyridines |
JPS6263520A (ja) * | 1985-09-14 | 1987-03-20 | Kyorin Pharmaceut Co Ltd | 抗リウマチ剤 |
CA2224517A1 (en) * | 1995-06-12 | 1996-12-27 | G.D. Searle & Co. | Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
US20040014761A1 (en) * | 1997-10-28 | 2004-01-22 | Place Virgil A. | Treatment of female sexual dysfunction with phosphodiesterase inhibitors |
ES2324540T3 (es) | 1998-05-27 | 2009-08-10 | Genzyme Corporation | Vectores aav para la fabricacion de medicamentos para la administracion potenciada por conveccion. |
CA2319495A1 (en) * | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
JP4828003B2 (ja) * | 1998-08-10 | 2011-11-30 | 杏林製薬株式会社 | 多発性硬化症治療薬 |
US20020068740A1 (en) * | 1999-12-07 | 2002-06-06 | Mylari Banavara L. | Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
US7135495B2 (en) * | 2000-03-09 | 2006-11-14 | Ono Pharmaceutical Co., Ltd. | Indole derivatives |
WO2001074811A2 (en) * | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Substituted 1,3-thiazole compounds, their production and use |
GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
KR100884709B1 (ko) * | 2000-09-14 | 2009-02-19 | 미쓰비시 타나베 파마 코퍼레이션 | 신규한 아미드 유도체의 광학 활성체 및 그의 의약적 용도 |
DE20020546U1 (de) * | 2000-12-04 | 2002-04-11 | Zumtobel Staff Gmbh, Dornbirn | Fassung für Kompaktleuchtstofflampen |
US20020137755A1 (en) * | 2000-12-04 | 2002-09-26 | Bilodeau Mark T. | Tyrosine kinase inhibitors |
US20040063685A1 (en) * | 2000-12-08 | 2004-04-01 | Juji Ilzawa | Combination Drugs |
US20040097555A1 (en) * | 2000-12-26 | 2004-05-20 | Shinegori Ohkawa | Concomitant drugs |
US20050080113A1 (en) * | 2001-06-11 | 2005-04-14 | Shigenori Ohkawa | Medicinal compositions |
CA2451288A1 (en) * | 2001-07-31 | 2003-02-13 | Pharmacia & Upjohn Company | Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines |
WO2003013513A1 (en) * | 2001-08-03 | 2003-02-20 | Takeda Chemical Industries, Ltd. | Stable emulsion composition |
WO2003014110A1 (fr) * | 2001-08-08 | 2003-02-20 | Takeda Chemical Industries, Ltd. | Derive de benzazepine, son procede de preparation et d'utilisation |
US7022689B2 (en) * | 2001-08-09 | 2006-04-04 | Kissei Pharmaceutical Co., Ltd. | 5-amidino-n-(2-aminophenethyl)-n-hydroxy-benzenesulffonamide derivative, medical composition containing the same, pharmaceutical use thereof and intermediate therefor |
US7338939B2 (en) * | 2003-09-30 | 2008-03-04 | New River Pharmaceuticals Inc. | Abuse-resistant hydrocodone compounds |
JP4292402B2 (ja) * | 2001-09-07 | 2009-07-08 | 小野薬品工業株式会社 | インドール誘導体化合物、それらの製造方法およびそれらを有効成分として含有する薬剤 |
JPWO2003040086A1 (ja) * | 2001-11-09 | 2005-03-03 | キッセイ薬品工業株式会社 | 5−アミジノ−2−ヒドロキシベンゼンスルホンアミド誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体 |
IL163866A0 (en) * | 2002-03-05 | 2005-12-18 | Ono Pharmaceutical Co | 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient |
US20040053842A1 (en) * | 2002-07-02 | 2004-03-18 | Pfizer Inc. | Methods of treatment with CETP inhibitors and antihypertensive agents |
US20050038063A1 (en) * | 2002-11-29 | 2005-02-17 | Kenneth Newman | Method of treating acute pain with unitary dosage form comprising ibuprofen and oxycodone |
CL2004000545A1 (es) * | 2003-03-18 | 2005-01-28 | Pharmacia Corp Sa Organizada B | Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul |
CL2004000544A1 (es) * | 2003-03-18 | 2005-01-28 | Pharmacia Corp Sa Organizada B | Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati |
US20040266743A1 (en) * | 2003-05-09 | 2004-12-30 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and a renin inhibitor |
US7261882B2 (en) * | 2003-06-23 | 2007-08-28 | Reagents Of The University Of Colorado | Methods for treating neuropathic pain by administering IL-10 polypeptides |
TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
US7534806B2 (en) * | 2004-12-06 | 2009-05-19 | Avigen, Inc. | Method for treating neuropathic pain and associated syndromes |
MX2007015789A (es) * | 2005-06-16 | 2008-02-15 | Mallinckrodt Inc | Nueva ruta de sintesis para opiatos de 14-hidroxilo a traves de 1-halo-tebaina o analogos. |
CA2623072A1 (en) * | 2005-09-26 | 2007-04-05 | Avigen, Inc. | Use of ibudilast for treating drug and behavioral addictions |
EP2026804A1 (en) * | 2006-05-31 | 2009-02-25 | Avigen, Inc. | Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
JP5352452B2 (ja) * | 2006-06-06 | 2013-11-27 | メディシノバ, インコーポレイテッド | 置換ピラゾロ[1,5−a]ピリジン化合物およびその使用方法 |
CA2669463A1 (en) * | 2006-11-09 | 2008-05-15 | Avigen, Inc. | Method for treating delirium |
-
2008
- 2008-01-29 WO PCT/US2008/001187 patent/WO2008094571A1/en active Application Filing
- 2008-01-29 ES ES08724934T patent/ES2392116T3/es active Active
- 2008-01-29 EP EP08724934A patent/EP2131841B1/en not_active Not-in-force
- 2008-01-29 DK DK08724934.8T patent/DK2131841T3/da active
- 2008-01-29 PL PL08724934T patent/PL2131841T3/pl unknown
- 2008-01-29 US US12/011,997 patent/US20080181876A1/en not_active Abandoned
- 2008-01-29 PT PT08724934T patent/PT2131841E/pt unknown
-
2010
- 2010-06-15 HK HK10105999.8A patent/HK1139856A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2131841A1 (en) | 2009-12-16 |
WO2008094571A1 (en) | 2008-08-07 |
US20080181876A1 (en) | 2008-07-31 |
PL2131841T3 (pl) | 2013-03-29 |
HK1139856A1 (en) | 2010-09-30 |
EP2131841B1 (en) | 2012-08-01 |
ES2392116T3 (es) | 2012-12-04 |
PT2131841E (pt) | 2012-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2016041I1 (lt) | Gydymo būdai panaudojant vaistus - amoniako gaudykles | |
BRPI0814359A2 (pt) | Método | |
BRPI0817226A2 (pt) | Método | |
BRPI0817726A2 (pt) | Método | |
BRPI0810206A2 (pt) | Método de tratar câncer | |
BRPI0910854A2 (pt) | métodos de tratamento | |
DK2212070T3 (da) | Fremgangsmåde til behandling af træ | |
DK2310034T3 (da) | Peptider til behandling af beta-amyloidose | |
DK2293816T3 (da) | Fremgangsmåder til behandling af reumatoid arthritis | |
DK2203551T3 (da) | Bifidobakterieart | |
DK3289876T3 (da) | Forbindelser til behandling af cancer | |
BRPI0919127A2 (pt) | métodos para tratamento de água | |
BRPI0813670A2 (pt) | Compostos para tratamento | |
DK2131841T3 (da) | Fremgangsmåder til behandling af akut smerte | |
DK2330887T3 (da) | Behandlingsindretning | |
DK2342346T3 (da) | Thermotoga til behandling af biomasse | |
DK2173831T3 (da) | Brøndbehandling | |
BRPI0821652A2 (pt) | tratamento de biocombustíveis | |
DK2164572T3 (da) | Carbamoyl-cyclohexaner til behandling af akut mani | |
BRPI0809678A2 (pt) | Métodos | |
DK2441462T3 (da) | Fremgangsmåde til behandling af type I-diabetes | |
BRPI0810416A2 (pt) | Método de hidroformação | |
BRPI0916818A2 (pt) | Método para tratamento de dentes sensíveis | |
DK2215314T3 (da) | Indretning til behandling af regnvand | |
DK2012814T3 (da) | Fremgangsmåder til behandling af autoimmunsygdomme |